Analyst Timothy Chiang works at CAPITAL ONE and is focused on the Healthcare sector with 132 price targets and ratings documented since 2016 spanning on 9 stocks. Previously, Timothy Chiang worked at BTIG. Analyst's average stock valuation to be materialised ratio is 24.23% with an average time for price targets to be met of 117.92 days.
Most recent stock forecast was given on AMPH, Amphastar Pharmaceuticals, Inc at 29-Jul-2022.
Timothy Chiang best performing recommendations are on PCRX (PACIRA BIOSCIENCES, INC).
The best stock recommendation documented was for TEVA (TEVA PHARMACEUTICAL INDUSTRIES LIMITED) at 2/14/2017. The price target of $34 was fulfilled within 1 day with a profit of $0.24 (0.71%) receiving and performance score of 7.11.
Average potential price target upside